Difference between revisions of "Mottahedin A"
From Bioblast
Beno Marija (talk | contribs) |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 10: | Line 10: | ||
{{Labelingperson}} | {{Labelingperson}} | ||
==Participated at== | ==Participated at== | ||
*[[ | ::::* [[IOC115 | IOC115 Schroecken AT]] | ||
Latest revision as of 11:55, 14 February 2018
| Name | Mottahedin Amin, |
|---|---|
| Institution | University of Gothenburg |
| Address | Medicineregatan 11, |
| City | Gothenburg |
| State/Province | |
| Country | Sweden |
| amin.mottahedin@neuro.gu.se | |
| Weblink | |
| O2k-Network Lab | SE Gothenburg Hagberg H |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Yin 2021 Nat Commun | 2021 | Yin Z, Burger N, Kula-Alwar D, Aksentijević D, Bridges HR, Prag HA, Grba DN, Viscomi C, James AM, Mottahedin A, Krieg T, Murphy MP, Hirst J (2021) Structural basis for a complex I mutation that blocks pathological ROS production. Nat Commun 12:707. |
| Mottahedin 2017 J Cereb Blood Flow Metab | 2017 | Mottahedin A, Svedin P, Nair S, Mohn CJ, Wang X, Hagberg H, Ek J, Mallard C (2017) Systemic activation of Toll-like receptor 2 suppresses mitochondrial respiration and exacerbates hypoxic-ischemic injury in the developing brain. J Cereb Blood Flow Metab 37:1192-8. |
